U.S. needs market-driven regulatory framework, von Eschenbach says

04/9/2013 | American City Business Journals

Medical device, diagnostics and biotech firms should collaborate and share intellectual property early to better address the complicated health problems they are aiming to treat, former FDA director Dr. Andrew von Eschenbach said in a speech Monday in Massachusetts. Von Eschenbach also urged that changes be made to the FDA, including adding a layer of regulation driven by industry.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC
Healthcare Compliance Manager
EY
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Health Plan CEO - Oregon
Witt/Kieffer
Eugene, OR
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC